MIRA
INFORM REPORT
|
Report Date : |
24.05.2013 |
IDENTIFICATION DETAILS
|
Name : |
IBA DOSIMETRY GMBH |
|
|
|
|
Registered Office : |
Bahnhofstrasse 5
Schwarzenbruck, 90592 |
|
|
|
|
Country : |
Germany |
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
1973 |
|
|
|
|
Com. Reg. No.: |
4262 |
|
|
|
|
Legal Form : |
Private Subsidiary |
|
|
|
|
Line of Business : |
Manufactures customised, high-end dosimetry equipment that
is used in hospitals. |
|
|
|
|
No. of Employees : |
145 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March, 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Germany |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
GERMANY - ECONOMIC OVERVIEW
The German economy - the fifth largest economy in the world
in PPP terms and Europe's largest - is a leading exporter of machinery,
vehicles, chemicals, and household equipment and benefits from a highly skilled
labor force. Like its Western European neighbors, Germany faces significant
demographic challenges to sustained long-term growth. Low fertility rates and
declining net immigration are increasing pressure on the country's social
welfare system and necessitate structural reforms. Reforms launched by the
government of Chancellor Gerhard SCHROEDER (1998-2005), deemed necessary to
address chronically high unemployment and low average growth, contributed to
strong growth in 2006 and 2007 and falling unemployment. These advances, as
well as a government subsidized, reduced working hour scheme, help explain the
relatively modest increase in unemployment during the 2008-09 recession - the
deepest since World War II - and its decrease to 6.5% in 2012. GDP contracted
5.1% in 2009 but grew by 4.2% in 2010, and 3.0% in 2011, before dipping to 0.7%
in 2012 - a reflection of low investment spending due to crisis-induced
uncertainty and the decreased demand for German exports from recession-stricken
periphery countries. Stimulus and stabilization efforts initiated in 2008 and
2009 and tax cuts introduced in Chancellor Angela MERKEL's second term
increased Germany's total budget deficit - including federal, state, and
municipal - to 4.1% in 2010, but slower spending and higher tax revenues
reduced the deficit to 0.8% in 2011. In 2012 Germany reached a budget surplus
of 0.1%. A constitutional amendment approved in 2009 limits the federal
government to structural deficits of no more than 0.35% of GDP per annum as of
2016 though the target was already reached in 2012. By 2014, the federal
government wants to balance its budget. Following the March 2011 Fukushima
nuclear disaster, Chancellor Angela Merkel announced in May 2011 that eight of
the country's 17 nuclear reactors would be shut down immediately and the
remaining plants would close by 2022. Germany hopes to replace nuclear power
with renewable energy. Before the shutdown of the eight reactors, Germany
relied on nuclear power for 23% of its electricity generating capacity and 46%
of its base-load electricity production.
|
Source
: CIA |
Company name and address
IBA
DOSIMETRY GMBH
|
Bahnhofstrasse 5 Schwarzenbruck, 90592 Germany
|
|
|
||||||||||||||||||||||||||||||||||||
Business Description
IBA Dosimetry GmbH manufactures customised, high-end
dosimetry equipment that is used in hospitals. It designs and develops a range
of radiotherapy and radiodiagnostic devices. The company offers detectors for beam
qualities and applications. It provides hardware maintenance contracts and
inspection and after sales services. The company also offers various
accessories, such as lifting tables and water reservoirs. It provides software
for various commissioning and quality assurance purposes. In addition, the
company conducts in-house research and design activities. It develops personal
computer-based, universal serial bus-powered, automatic precision instruments
to measure dose rate, exposure time and noninvasively practical peak voltage.
The company additionally operates a laboratory for the calibration of
dosimeters that are used in radiation therapy.
Industry
|
Industry |
|
|
ANZSIC 2006: |
|
|
NACE 2002: |
|
|
NAICS 2002: |
|
|
UK SIC 2003: |
|
|
UK SIC 2007: |
|
|
US SIC 1987: |
Key Executives
|
Name |
Title |
|
Olivier Legrain |
Managing director |
|
Robby Plompen |
Managing director |
News
|
Title |
Date |
|
RaySearch Laboratories AB (publ)
Interim Report January 1 - March 31, 2013 |
16-May-2013 |
|
RaySearch receives 510(k) clearance
for RayStation® 3.5 |
15-May-2013 |
|
Major treatment center in Maryland
selects RayStation |
22-Apr-2013 |
|
RaySearch licenses technology from
GSI |
12-Apr-2013 |
|
RaySearch's 2012 Annual Report
Published |
27-Mar-2013 |
|
RayStation® 3.5 released |
15-Mar-2013 |
Registered No.(DEU): 4262
1 - Profit & Loss Item Exchange Rate: USD 1 = EUR 0.7191895
2 - Balance Sheet Item Exchange Rate:
USD 1 = EUR 0.770327
|
|
|
|
|
|
ANZSIC 2006 Codes: |
||
|
3720 |
- |
Pharmaceutical and Toiletry Goods Wholesaling |
|
2412 |
- |
Medical and Surgical Equipment Manufacturing |
|
NACE 2002 Codes: |
||
|
5146 |
- |
Wholesale of pharmaceutical goods |
|
3310 |
- |
Manufacture of medical and surgical equipment and
orthopaedic appliances |
|
NAICS 2002 Codes: |
||
|
424210 |
- |
Drugs and Druggists' Sundries Merchant Wholesalers |
|
33911 |
- |
Medical Equipment and Supplies Manufacturing |
|
US SIC 1987: |
||
|
5047 |
- |
Medical, Dental, and Hospital Equipment and Supplies |
|
384 |
- |
Surgical, Medical, and Dental Instruments and Apparatus |
|
UK SIC 2003: |
||
|
5146 |
- |
Wholesale of pharmaceutical goods |
|
3310 |
- |
Manufacture of medical and surgical equipment and
orthopaedic appliances |
|
UK SIC 2007: |
||
|
4646 |
- |
Wholesale of pharmaceutical goods |
|
3250 |
- |
Manufacture of medical and dental instruments and supplies |
IBA Dosimetry GmbH manufactures customised, high-end dosimetry equipment that is used in hospitals. It designs and develops a range of radiotherapy and radiodiagnostic devices. The company offers detectors for beam qualities and applications. It provides hardware maintenance contracts and inspection and after sales services. The company also offers various accessories, such as lifting tables and water reservoirs. It provides software for various commissioning and quality assurance purposes. In addition, the company conducts in-house research and design activities. It develops personal computer-based, universal serial bus-powered, automatic precision instruments to measure dose rate, exposure time and noninvasively practical peak voltage. The company additionally operates a laboratory for the calibration of dosimeters that are used in radiation therapy.
|
|
|
Bank: |
Raiffeisenbank Altdorf-Feucht, Commerzbank vormals
Dresdner Bank |
Corporate
Family
Corporate Structure News:
Total Corporate Family Members: 2
|
|
|
Company Name |
Company Type |
Location |
Country |
Industry |
Sales |
Employees |
|
Mediflash Holding AB |
Parent |
|
|
|
|
|
|
Subsidiary |
Schwarzenbruck, Bayern |
Germany |
Personal and Household Products |
|
145 |
Executives
|
|
|
|||
|
Managing director |
Managing Director |
|||
|
Managing director |
Managing Director |
News
|
RaySearch
Laboratories AB (publ) Interim Report January 1 - March 31, 2013 |
16-May-2013 |
|
RaySearch
receives 510(k) clearance for RayStation® 3.5 |
15-May-2013 |
|
Major treatment
center in Maryland selects RayStation |
22-Apr-2013 |
|
RaySearch
licenses technology from GSI |
12-Apr-2013 |
|
RaySearch's
2012 Annual Report Published |
27-Mar-2013 |
|
RayStation®
3.5 released |
15-Mar-2013 |
|
C-RAD AB:
Year End Report 2012 |
26-Feb-2013 |
|
RaySearch
Laboratories AB (publ) Year-end Report 2012 |
14-Feb-2013 |
|
First
RayStation order in France |
01-Feb-2013 |
|
C-Rad AB:
C-RAD AB: IBA frame order 2013 |
24-Jan-2013 |
|
C-RAD AB:
IBA frame order 2013 |
24-Jan-2013 |
Annual Profit & Loss
|
|
31-Dec-2011 |
31-Dec-2010 |
31-Dec-2009 |
|
Period Length |
12 Months |
12 Months |
12 Months |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate (Period
Average) |
0.71919 |
0.755078 |
0.719047 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Taxes and social security costs |
1.8 |
1.6 |
1.5 |
|
Total payroll costs |
13.6 |
12.2 |
11.3 |
|
Cost of stock depreciation and amortisation |
0.2 |
- |
- |
|
Fixed asset depreciation and amortisation |
1.2 |
1.1 |
1.0 |
|
Other operating costs |
17.4 |
13.2 |
9.3 |
|
Net operating income |
1.6 |
8.4 |
3.9 |
|
Other income |
0.2 |
0.1 |
0.1 |
|
Interest payable on loans |
0.2 |
0.2 |
0.2 |
|
Total expenses |
0.0 |
0.1 |
0.1 |
|
Profit before tax |
1.6 |
8.4 |
3.9 |
|
Extraordinary income |
- |
0.0 |
- |
|
Provisions |
4.0 |
4.6 |
2.6 |
|
Extraordinary result |
- |
0.0 |
- |
|
Other taxes |
0.0 |
0.0 |
0.0 |
|
Total taxation |
0.5 |
2.4 |
1.1 |
|
Net profit |
1.0 |
6.0 |
2.8 |
Annual
Balance Sheet
Financials in: USD (mil)
|
|
31-Dec-2011 |
31-Dec-2010 |
31-Dec-2009 |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate |
0.770327 |
0.745406 |
0.696986 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Issued capital |
0.1 |
0.1 |
0.1 |
|
Capital reserves |
2.7 |
2.7 |
2.9 |
|
Profits for the year |
15.9 |
15.4 |
10.0 |
|
Profit brought forward from previous year(s) |
14.9 |
9.3 |
7.1 |
|
Total stockholders equity |
18.7 |
18.3 |
13.0 |
|
Deferred taxation |
0.1 |
1.5 |
0.4 |
|
Other provisions |
3.7 |
3.2 |
2.3 |
|
Provisions and allowances |
3.8 |
4.6 |
2.7 |
|
Owing to group/associated companies |
3.5 |
- |
- |
|
Total long-term liabilities |
3.5 |
- |
- |
|
Trade creditors |
0.5 |
0.4 |
0.5 |
|
Advances received |
0.9 |
0.2 |
0.0 |
|
Taxation and social security |
3.2 |
1.4 |
0.6 |
|
Due to group companies |
3.2 |
4.7 |
6.6 |
|
Total current liabilities |
7.8 |
6.7 |
7.8 |
|
Total liabilities (including net worth) |
33.8 |
29.6 |
23.5 |
|
Patents |
0.1 |
0.1 |
0.1 |
|
Goodwill |
0.8 |
1.2 |
1.7 |
|
Intangibles |
0.9 |
1.2 |
1.7 |
|
Machinery and tools |
0.8 |
1.0 |
1.0 |
|
Fixed assets under construction |
0.7 |
0.1 |
0.1 |
|
Total tangible fixed assets |
2.0 |
1.7 |
1.7 |
|
Other financial assets |
- |
- |
0.2 |
|
Total financial assets |
- |
- |
0.2 |
|
Total non-current assets |
2.9 |
2.9 |
3.7 |
|
Raw materials |
2.9 |
3.2 |
2.4 |
|
Work in progress |
1.6 |
2.7 |
1.7 |
|
Finished goods |
1.2 |
1.8 |
1.5 |
|
Prepayments |
0.3 |
0.2 |
0.2 |
|
Net stocks and work in progress |
5.9 |
7.8 |
5.9 |
|
Trade debtors |
4.2 |
6.0 |
4.3 |
|
Other receivables |
3.5 |
1.0 |
0.6 |
|
Total receivables |
21.2 |
17.0 |
11.2 |
|
Owing from associated companies |
13.4 |
10.0 |
6.2 |
|
Cash and liquid assets |
3.7 |
1.8 |
2.7 |
|
Total current assets |
30.8 |
26.6 |
19.8 |
|
Prepaid expenses and deferred costs |
0.1 |
0.1 |
0.1 |
|
Total assets |
33.8 |
29.6 |
23.5 |
Annual
Ratios
Financials in: USD (mil)
|
|
31-Dec-2011 |
31-Dec-2010 |
31-Dec-2009 |
|
Period Length |
12 Months |
12 Months |
12 Months |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate |
0.770327 |
0.745406 |
0.696986 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Current ratio |
39.37 |
39.78 |
25.46 |
|
Acid test ratio |
31.79 |
28.09 |
17.89 |
|
Total liabilities to net worth |
0.06% |
0.04% |
0.06% |
|
Net worth to total assets |
0.06% |
0.06% |
0.06% |
|
Current liabilities to net worth |
0.04% |
0.04% |
0.06% |
|
Current liabilities to stock |
0.13% |
0.09% |
0.13% |
|
Fixed assets to net worth |
0.02% |
0.02% |
0.03% |
|
Return on assets |
0.00% |
0.02% |
0.01% |
|
Shareholders' return |
0.01% |
0.03% |
0.02% |
|
Profit per employee |
0.52 |
3.55 |
1.65 |
|
Average wage per employee |
6.77 |
7.18 |
6.76 |
|
Net worth |
18.7 |
18.3 |
13.0 |
|
Number of employees |
144 |
128 |
120 |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.99 |
|
|
1 |
Rs.84.19 |
|
Euro |
1 |
Rs.71.86 |
INFORMATION DETAILS
|
Report Prepared
by : |
SDA |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.